REFERENCES
- Lasic D.D., Papahadjopoulos D. Science 1995; 267: 1275–1276
- Sparano J.A., Winer E.P. Semin. Oncol. 2001; 28: 32–40
- Campbell R.B., Balasubranian S.V., Straubinger R.M. J. Pharm. Sci. 2001; 90: 1091–1095
- Schiffelers R., Storm G., Bakker-Woudenberg I. J. Antimicrob. Chemother. 2001; 48: 333–344
- Mezei M. Drug Permeation Enhancement: Theory and Applications, D.S. Hsich. DNLM, New York 1994; 171–198
- Krishana R., Webb M.S., St. Onge G., Mayer L.D. J. Pharmacol. Ther. 2001; 298: 1206–1212
- Ogiso T., Niinaka N., Iwaki M. J. Pharm. Sci. 1996; 85: 57–64
- Canto G.S., Dalmora S.L., Oliveira A.G. Drug Dev. Ind. Pharm. 1999; 25(12)1235–1239
- Tollemar J., Klingspor L., Rindgen O. Clin. Microbiol. Infec. 2001; 7: 68–79
- Maghraby G.M.E.L., Williams A.C., Barry B.W. J. Pharm. Pharmacol. 2001; 53: 1069–1077
- Vyas S.P., Sihorkar V., Dubey P.K. Pharmazie 2001; 56: 554–560
- Banerjee R. J. Biomater. Appl. 2001; 16: 3–21
- Takeuchi H., Kojima H., Yamamoto H., Kawashima Y. Biol. Pharm. Bull. 2001; 24: 795–799
- Axelsson B. Adv. Drug Del. Rev. 1989; 3: 391–404
- Chattaraj S.C., Das S.K. Drug Dev. Ind. Pharm. 1996; 22: 555–559
- Giovannetti M., Machado M.A.C., Borrelli M., Jr., Ikejiri C.I., Alonso N., Branco P.D. Rev. Hosp. Clin. Fac. Med. Univ. São Paulo 1993; 48: 39–42
- Muller-Vahl H. Lancet 1983; 7: 1050, May
- Campbell W.I., Watters C.H. Br. J. Anaesth. 1989; 62: 545–547
- Campbell W.I., Watters C.H. Br. J. Anaesth. 1991; 67: 803–804
- Kadir F., Eling W.M.C., Abrahams D., Zuidema J., Crommelin D.J.A. Int. J. Clin. Pharmacol., Ther. Toxicol. 1992; 30: 374–382
- Pillans P.I., O'Connor N. Ann. Pharmacother. 1995; 29: 264–266
- Burnett S., Davy C.W., Jackson M.R. Int. J. Tissue React. 1981; 111: 107
- Litterst C., Sieber S.M., Copley M., Parker R.J. Toxicol. Appl. Pharmacol. 1982; 64: 517–528
- Forssen E.A., Tokes Z.A. Cancer Treat. Rep. 1983; 67: 481–484
- Surber C., Dubach U.C. Arzneim. Forsch. 1989; 39(II)1586–1589
- Diness V. Acta Pharmacol. Toxicol. 1985; 56: 410–415
- Svendsen O., Hojelse F., Bagdon R.E. Acta Pharmacol. Toxicol. 1985; 56: 183–190
- New R.R.C. Liposomes. A Practical Approach. IRL Press, Oxford 1997; 301 pp
- Lasic D.D., Papahadjopoulos D. Medical Applications of Liposomes. Elsevier, Amsterdam 1998; 779 pp.
- Lasic D.D. Liposomes in Gene Delivery. CRC, Boca Raton 1997; 295 pp.
- Rosoff M. Vesicles. Marcel Dekker, New York 1996; 445–746
- Woodle M.C., Storm G. Long Circulating Liposomes. New Drugs, New Therapeutics. Springer-Verlag, Berlin 1998; 301 pp.
- Guterres S.S. Etude Pharmacothecnique, Pharmacocinetique et de Tolerances Digestive et Tissulaire des Nanocapsules de Diclofenac. Université de Paris-SUD. 1995; 195 pp., These de Doctorat
- Guterres S.S., Fessi H., Barrat G., Puisieux F., Devissaguet J.P. J. Biomater. Sci. Polym. Ed. 2000; 11: 1347–1355
- Hsu H., Watanabe J. Chem. Pharm. Bull. 1983; 31: 626–631
- Olling M., Van Twillert K., Wester P., Boink A.B.T. J. Vet. Pharmacol. Ther. 1995; 18: 34–37
- Surber C., Sucker H. Pharm. Res. 1987; 4: 490–494
- Sutton S.C., Evans L.A.F., Rinaldi M.T.S., Norton K.A. Pharm. Res. 1996; 13: 1514–1518